Loading clinical trials...
Loading clinical trials...
MEK inhibitors (trametinib, cobimetinib, selumetinib or binimetinib) have been used since 2016 to treat metastatic melanoma, by targeting the MAPK pathway Neuromuscular complications (neuropathy, myas...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Central Hospital, Nancy, France
NCT06290141 · Chronic Inflammatory Demyelinating Polyneuropathy
NCT07558850 · Rheumatoid Arthritis, Dermatomyositis, and more
NCT00017914 · Dermatomyositis, Polymyositis, and more
NCT06614322 · Painful Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain (DPN), and more
NCT07264426 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP, and more
CHRU Nancy
Nancy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions